Corbus Pharmaceuticals Holdings, Inc.
CRBP
$10.09
$0.010.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -101.90M | -84.53M | -78.54M | -67.51M | -57.95M |
| Total Depreciation and Amortization | 199.00K | 201.00K | 233.00K | 318.00K | 420.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 76.00K |
| Total Other Non-Cash Items | 5.57M | 4.87M | 4.69M | 4.95M | 5.01M |
| Change in Net Operating Assets | 9.46M | 5.82M | 9.12M | 2.74M | -5.46M |
| Cash from Operations | -86.67M | -73.64M | -64.49M | -59.51M | -57.90M |
| Capital Expenditure | -19.00K | -13.00K | -7.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.23M | 2.70M | -1.63M | 64.23M | 29.23M |
| Cash from Investing | 3.21M | 2.69M | -1.64M | 64.23M | 29.23M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | -10.90M |
| Issuance of Common Stock | 86.50M | 77.43M | 77.43M | 2.85M | 35.94M |
| Repurchase of Common Stock | -- | -- | -- | -13.00K | -13.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 86.50M | 77.43M | 77.43M | 2.84M | 25.03M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.04M | 6.48M | 11.29M | 7.56M | -3.64M |